Paxlovid Medication
Paxlovid medication requires careful assessment from a physician. The medication is initiated as quickly as possible after coronavirus symptoms have emerged but no later than 5 days from the start of symptoms.
The risk groups for preventive medication against RSV have been confirmed
In Finland, nirsevimab will be offered to all children born during the 2024-2025 winter RSV epidemic and to those under three months of age when the epidemic starts.
Client billing and instructions
On this page, you can find information and instructions on client billing.
Mpox
Mpox (formerly monkeypox) is poorly transmitted between people and is not typically transmitted in brief encounters in everyday life. However, if you suspect an infection, contact the health care services by phone.
Frequently asked questions about influenza and COVID-19 vaccinations
On this page, you can find answers to frequently asked questions about influenza and COVID-19 vaccinations. If you cannot find an answer to your question, please contact your own health centre.
Distribution of TYKS Foundation research grants to a new level in 2024
In 2024, the TYKS Foundation will allocate significantly more money to medical and health sciences research than before. This is enabled by significant donations received by the Foundation.
Tyks Hospital Services
Contact information on the management of social and health care services
Here you can find the contact information on the key persons within the health care and social welfare services of the Wellbeing Services County of Southwest Finland.
TYKS Foundation travel grants
TYKS Foundation has awarded the 2024 travel grants for researchers in medicine and health sciences. The €42,000 now awarded is part of the largest grant award in the foundation's history, totalling €300,000. The significantly higher award has been made possible by the significant donations…
More than one million donated to the TYKS Foundation
The TYKS Foundation has received a bequest of 1.6 million euros. The record-breaking donation is stated in the will of Jarmo Karppi (1953-2022) from Kaarina.
